Stereotaxis (STXS) Share-based Compensation (2010 - 2026)
Stereotaxis' (STXS) quarterly Share-based Compensation came in at $4.1 million in Q1 2026, up 10.03% year-over-year from $3.7 million in Q1 2025, and up 67.65% quarter-over-quarter from $2.4 million in Q4 2025.
Analysis
Stereotaxis (STXS) Share-based Compensation (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Share-based Compensation for 17 consecutive years, with $4.1 million the latest figure, recorded in Q1 2026.
- On a quarterly basis, Share-based Compensation rose 10.03% year-over-year to $4.1 million in Q1 2026; TTM through Mar 2026 was $4.1 million, a 10.03% increase from a year earlier, with the FY2025 full-year figure at $9.9 million, down 4.0% from the prior year.
- Share-based Compensation was $4.1 million for Q1 2026 at Stereotaxis, up from $2.4 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $3.4 billion in Q2 2022 and troughed at $2.4 million in Q4 2025.
- A 5-year average of $202.6 million and a median of $3.8 million in 2023 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation surged 59288.18% in 2022 and tumbled 99.86% in 2023, its largest moves.
- Over 5 years, Share-based Compensation stood at $2.7 million in 2022, then fell by 1.27% to $2.6 million in 2023, then declined by 2.62% to $2.6 million in 2024, then declined by 4.67% to $2.4 million in 2025, then soared by 67.65% to $4.1 million in 2026.
- The last three Share-based Compensation figures came in at $4.1 million (Q1 2026), $2.4 million (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn | 4.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 4.10 Mn |
| Dec 31, 2025 | 2.45 Mn |
| Sep 30, 2025 | 4.32 Mn |
| Jun 30, 2025 | 4.37 Mn |
| Mar 31, 2025 | 3.73 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Sep 30, 2024 | 3.96 Mn |
| Jun 30, 2024 | 4.10 Mn |
| Mar 31, 2024 | 3.47 Mn |
| Dec 31, 2023 | 2.64 Mn |
| Sep 30, 2023 | 3.77 Mn |
| Jun 30, 2023 | 4.60 Mn |
| Mar 31, 2023 | 3.81 Mn |
| Dec 31, 2022 | 2.67 Mn |
| Sep 30, 2022 | 5.60 Mn |
| Jun 30, 2022 | 3.39 Bn |
| Mar 31, 2022 | 3.48 Mn |
| Dec 31, 2021 | 2.61 Mn |
| Sep 30, 2021 | 5.80 Mn |
| Jun 30, 2021 | 5.70 Mn |